A Multicenter, Randomized, Placebo Controlled, Double-blinded, Phase 4 to Evaluate the Efficacy and Safety of DWJ1464 in Patients With Chronic Liver Disease

Conditions: Chronic Liver Disease Interventions: Drug: DWJ1464; Drug: Placebo of DWJ1464 Sponsors: Daewoong Pharmaceutical Co. LTD. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials